Personal Staff Webpage:
Name: Rabaa Al-Rousan, M.S.
Biography
Ph.D. Student Biomedical Sciences
Marshall University
Present
M.S. Molecular Physiology & Biophysics
The University of Iowa
May, 2007
B.S. Pharmacy
Jordan University of Science & Technology
February, 2004
Current Research Area / Interests
My research interest is in the area of cardiovascular pathophysiology and pharmacology. Currently, I’m working on a project examining the efficacy of deferasirox in preventing complications of iron overload with a special emphasis on the cardiovascular system. Iron-induced cardiovascular disease is the leading cause of death in iron-overloaded patients. Deferasirox is a novel once daily oral iron chelator that was recently approved for the treatment of transfusional iron overload. Our study aims to investigate whether deferasirox is capable of removing cardiac iron and improving iron-induced pathogenesis of the heart using the iron overload gerbil model.
Recent Publications
1) Alkhateeb FM, Unni E, Latif DA, Shawaqfeh MS, Al-Rousan RM. Physicians Attitudes towards Collaborative Agreement with Pharmacists and their Expectations of Pharmacists Responsibilities in West Virginia. JAPhA. 2009. (In press)
2) Al-Rousan RM, Satyanarayana P, Laurino JP, Kakarla SK, Gutta AK, Walker EM, Blough ER. Deferasirox Removes Cardiac Iron and Attenuates Oxidative Stress in the Iron-Overloaded Gerbil. American Journal of Hematology 2009 (in press)
